![]()
|
|
||||||||
From the
1 From the Department of Pathological Biochemistry, Atomic Disease Institute, Nagasaki University School of Medicine, Sakamoto-cho, Nagasaki-shi, Japan
Lipoamide dehydrogenase (reduced nicotinamide adenine dinucleotide:lipoamide oxidoreductase, EC 1.6.4.3) has been isolated from acid-precipitated human liver particles in a highly purified state by a freezing and thawing technique instead of the heat treatment used by other workers. The enzyme was found to have a molecular weight of 138,000, and to contain 2 moles of flavin adenine dinucleotide per mole of protein. In these respects, as in substrate specificity, Michaelis constant, absorption spectrum, and kinetic parameters, the enzyme is similar to preparations isolated from bovine liver, pig heart, and bacteria. This enzyme catalyzed the reduction of nicotinamide adenine dinucleotide by dihydrolipoamide and exhibited diaphorase and transhydrogenase activities. If the enzyme was incubated with the dithiol inhibitors such as arsenite and cadmium chloride in the presence of NADH, lipoamide dehydrogenase and transhydrogenase activities were strongly inhibited, but diaphorase activity was enhanced.
Lipoamide Dehydrogenase from Human Liver
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
F. Petrat, S. Paluch, E. Dogruoz, P. Dorfler, M. Kirsch, H.-G. Korth, R. Sustmann, and H. de Groot Reduction of Fe(III) Ions Complexed to Physiological Ligands by Lipoyl Dehydrogenase and Other Flavoenzymes in Vitro: IMPLICATIONS FOR AN ENZYMATIC REDUCTION OF Fe(III) IONS OF THE LABILE IRON POOL J. Biol. Chem., November 21, 2003; 278(47): 46403 - 46413. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |